Clinical analysis of primary choriocarcinoma in 13 male patients and review of literatures

Jiang Fan

2014-01-01

Journal of reproductive medicine

Abstract:Objective:To analyze the management and prognosis of primary choriocarcinoma in male patients.Methods:The clinical records of primary choriocarcinoma in male patients who were treated in Peking Union Medical College Hospital(PUMCH)since 1990 were analyzed retrospectively.The literatures concerning the clinical conditions were reviewed.Results:Median survival interval was 54months in PUMCH patients.All patients were treated with operation,and twelve of them were treated with combined chemotherapy.Up to March 2013,six patients were still alive,and the follow-up time was 21-138months.According to the data of our 13patients and 100literature patients,median survival interval was 10months(ranges,6.4-13.6months).Most primary sites were testes(36.2%)and most patients(70.9%)`had metastatic lesions at the time of diagnosis.On the basis of univariate and multivariate analysis,patients' age≤34 years old,presence of other ingredients histologically,and combined chemotherapy were significantly associated with a long median survival interval.Conclusions:Primary choriocarcinomas in male is an extremely rare disease,and the prognosis is much worse than that of gestational choriocarcinomas.The patients' age≤34years old,presence of other ingredient histologically,and combined chemotherapy are strong indicators of better prognosis in malepatients with primary choriocarcinomas.